192 related articles for article (PubMed ID: 1067623)
1. Evidence for and against the involvement of N,N-dimethyl-tryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in schizophrenia.
Gillin JC; Wyatt RJ
Psychopharmacol Bull; 1976 Oct; 12(4):12-3. PubMed ID: 1067623
[No Abstract] [Full Text] [Related]
2. The significance of some biochemical abnormalities in schizophrenia.
Rodnight R
Acta Neurol (Napoli); 1975; 30(1):85-101. PubMed ID: 1063539
[No Abstract] [Full Text] [Related]
3. Accumulation of N,N-dimethyltryptamine in rat brain cortical slices.
Sangiah S; Gomez MV; Domino EF
Biol Psychiatry; 1979 Dec; 14(6):925-36. PubMed ID: 41604
[TBL] [Abstract][Full Text] [Related]
4. N,N-dimethyltryptamine--a possible relationship to schizophrenia?
Wyatt RJ; Gillin JC; Kaplan J; Stillman R; Mandel L; Ahn HS; VandenHeuvel WJ; Walker RW
Adv Biochem Psychopharmacol; 1974; 11(0):299-313. PubMed ID: 4602668
[No Abstract] [Full Text] [Related]
5. The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine.
Gillin JC; Kaplan J; Stillman R; Wyatt RJ
Am J Psychiatry; 1976 Feb; 133(2):203-8. PubMed ID: 1062171
[TBL] [Abstract][Full Text] [Related]
6. Editorial: Dimethyltryptamine and psychosis.
Lancet; 1974 Jul; 2(7873):140-1. PubMed ID: 4135558
[No Abstract] [Full Text] [Related]
7. Urinary excretion of dimethyltryptamine in liver disease.
Checkley SA; Oon MC; Rodnight R; Murphy MP; Williams RS; Birley JL
Am J Psychiatry; 1979 Apr; 136(4A):439-41. PubMed ID: 284722
[TBL] [Abstract][Full Text] [Related]
8. The indole hallucinogens, N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), have different effects from mescaline on rat shuttlebox avoidance.
Stoff DM; Gorelick DA; Bozewicz T; Bridger WH; Gillin JC; Wyatt RJ
Neuropharmacology; 1978 Dec; 17(12):1035-40. PubMed ID: 284199
[No Abstract] [Full Text] [Related]
9. Optimization of separation and online sample concentration of N,N-dimethyltryptamine and related compounds using MEKC.
Wang MJ; Tsai CH; Hsu WY; Liu JT; Lin CH
J Sep Sci; 2009 Feb; 32(3):441-5. PubMed ID: 19137528
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the separation of nine tryptamine standards based on gas chromatography, high performance liquid chromatography and capillary electrophoresis methods.
Wang MJ; Liu JT; Chen HM; Lin JJ; Lin CH
J Chromatogr A; 2008 Feb; 1181(1-2):131-6. PubMed ID: 18177659
[TBL] [Abstract][Full Text] [Related]
11. Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine.
Jacob MS; Presti DE
Med Hypotheses; 2005; 64(5):930-7. PubMed ID: 15780487
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the brain levels of N,N-dimethyltryptamine and alpha, alpha, beta, beta-tetradeutero-N-N-dimethyltryptamine following intraperitoneal injection. The in vivo kinetic isotope effect.
Barker SA; Beaton JM; Christian ST; Monti JA; Morris PE
Biochem Pharmacol; 1982 Aug; 31(15):2513-6. PubMed ID: 6812592
[TBL] [Abstract][Full Text] [Related]
13. Effects of pargyline and SKF-525A on brain N,N-dimethyltryptamine concentrations and hyperactivity in mice.
Morinan A; Collier JG
Psychopharmacology (Berl); 1981; 75(2):179-83. PubMed ID: 6798607
[TBL] [Abstract][Full Text] [Related]
14. The electronic and serotonin receptor binding affinity properties of N,N-dimethyltryptamine analogs.
Glennon RA; Gessner PK
Res Commun Chem Pathol Pharmacol; 1977 Nov; 18(3):453-65. PubMed ID: 270770
[TBL] [Abstract][Full Text] [Related]
15. "In vivo biosynthesis of N,N-dimethyltryptamine, 5-MeO-N,N-dimethyltryptamine, and bufotenine in E.coli".
Friedberg LM; Sen AK; Nguyen Q; Tonucci GP; Hellwarth EB; Gibbons WJ; Jones JA
Metab Eng; 2023 Jul; 78():61-71. PubMed ID: 37230161
[TBL] [Abstract][Full Text] [Related]
16. Ontogeny of N,N-dimethyltryptamine and related indolealkylamine levels in neonatal rats.
Beaton JM; Morris PE
Mech Ageing Dev; 1984 Jun; 25(3):343-7. PubMed ID: 6588281
[TBL] [Abstract][Full Text] [Related]
17. Hypothetical biosynthetic pathways of pharmaceutically potential hallucinogenic metabolites in Myristicaceae, mechanistic convergence and co-evolutionary trends in plants and humans.
Barman R; Kumar Bora P; Saikia J; Konwar P; Sarkar A; Kemprai P; Proteem Saikia S; Haldar S; Slater A; Banik D
Phytochemistry; 2024 Feb; 218():113928. PubMed ID: 38035973
[TBL] [Abstract][Full Text] [Related]
18. Failure of N,N-dimethyltryptamine to evoke tolerance in cats.
Gillin JC; Cannon E; Magyar R; Schwartz M; Wyatt RJ
Biol Psychiatry; 1973 Dec; 7(3):213-20. PubMed ID: 4519415
[No Abstract] [Full Text] [Related]
19. The in vitro identification of dimethyltryptamine (DMT) in mammalian brain and its characterization as a possible endogenous neuroregulatory agent.
Christian ST; Harrison R; Quayle E; Pagel J; Monti J
Biochem Med; 1977 Oct; 18(2):164-83. PubMed ID: 20877
[No Abstract] [Full Text] [Related]
20. Investigating the ability of the microbial model Cunninghamella elegans for the metabolism of synthetic tryptamines.
Grafinger KE; Wilke A; König S; Weinmann W
Drug Test Anal; 2019 May; 11(5):721-729. PubMed ID: 30462883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
